Update on the U.S. Food and Drug Administration regulatory approach to over-the-counter cholesterol-lowering drugs.
Orloff
D G
DG
Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, USA.
D000924:Anticholesteremic Agents / Q000592:standards*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007880:Legislation, Drug; D004366:Nonprescription Drugs / Q000592:standards*; D012449:Safety; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D000924:Anticholesteremic Agents; D004366:Nonprescription Drugs